Artennua is an optimized version of Artemisia annua, a medicinal plant used for centuries in Chinese Medicine that is the only natural source of Artemisinin. Artemisinin is the molecule recommended by the WHO to treat malaria.
Artemisinin, its derivatives, and other secondary metabolites contained in the plant Artemisia annua, have the potential to treat a broad range of diseases and afflictions. However, Artemisia annua produces very low quantities of artemisinin and thus its global supply is limited.
As scientists and social entrepreneurs, we have used natural plant biopharming methods to improve some characteristics of the Artemisia annua plant meaning its therapeutic properties can now be exploited more extensively.
The immune system in all organisms aims to protect the body from different threats such as diseases and infections. Whether it is a bacteria, a virus or a parasite,pet’s immune system is the host’s way of defense and prevention against these types of pathogens. That is why it is important to keep this mechanism strong…
Canine Leishmaniasis (Lcan) is a zoonotic disease endemic in 98 tropical countries that can generate severe systemic pictures of different considerations in dogs. In Europe, the causal agent of the disease is Leishmania infantum, transmitted by the bite of a group of mosquitoes of the genus Phlebotomus, which is able to reprogram the cellular microenvironment…
Artemisinin inhibits the activation of spinal TLR4 transmembrane protein during postoperative pain. The ART nanocapsule had a more potent and longer antinociceptive effect than free ART or morphine. Whether in animals or humans, pain management to date has been achieved through the use of non-steroidal anti-inflammatory drugs (NSAIDs) and opioids that may not always be…
